NAME INDICATION ACTION CONTRAINDICAT ROUTE AND NURSING

ION/ DOSAGE RESPONSIBILITY

ADVERSE
REACTION
GENERIC Paracetamol may Contraindication: 300mg TIV Q4 Assess patient’s fever
NAME: -To relieve mild to cause analgesia by PRN fo r fever or pain: Type of
moderate pain due to inhibiting CNS Hypersensitivity to pain,location,
Paracetamol things such as prostaglandin acetaminophen or intensity,duration,
headache,muscle synthesis. The phenacetin; use with temperature,and
and joint mechanism alcohol diaphoresis.>Assess
BRAND pain,backache and of morphine is allergicreactions:
NAME: period pains. It is believed to involve Adverse reaction: rash,urticaria; if these
also used to bring decreased Hematologic: occur,drug may have to
Biogesic down a high permeability of the bediscontinued.>Teach patient
temperature. For this cell membrane hemolyticanemia, torecognize signs of chronic
reason,paracetamol tosodium, which leukopenia,neutropeni overdose:bleeding,
can be given to results in a,pancytopenia,throm bruising,malaise, fever,
children afte diminished bocytopenia. sorethroat.>Tell patient to
rvaccinations to transmission notifyprescriber for pain/fever
Hepatic: liver
prevent post- of pain impulses lasting for morethan 3 days.
damage, jaundice
immunization therefore analgesia
pyrexia. Metabolic:
Hypoglycemia
Skin:rash,urticuria
 NAME INDICATION ACTION CONTRAINDI ROUTE AND NURSING
CATION/ DOSAGE RESPONSIBILITY
ADVERSE
REACTION
GENERIC Short-term treatment Gastric acid-pump Diarrhea, nausea 40mg IVT OD
NAME: of doudenal ulcer; firstinhibitor: suppresses and vomiting, While on NPO Assess Vital Signs
line therapy in gastric acid secretion fatigue,
Omeprazole by specific inhibition constipation, Check for abdominal Pain,
treatment of heartburn
of the hydrogen- emesis, Diarrhea or
or gastroesophageal potassium ATP as constipation.
BRAND reflux disease (GERD) enzyme system at the
NAME: secretory surface of Evaluate fluid and intake
Long-term therapy; the gastric parietal
Prillosec treatment of pathologic cells; blocks the final Watch for elevated liver
hypersecretory step of acid function test results
condition production.
Tell patient to take 30-60
minutes before a meal,
preferably in morning.

Instruct patient to swallow

capsules or tablets whole and
no to chew or crash them.

Caution patient to avoid

driving and other hazardous
activities until he know drug
effects concentration and
alertness
NAME INDICATION ACTION CONTRAINDI ROUTE AND NURSING
CATION/ DOSAGE RESPONSIBILITY
ADVERSE
REACTION
GENERIC Inhibits bacterial DNA Inhibits bacterial Contraindicated 400 mg TIV -Assess for infection prior to
NAME: synthesis by inhibiting DNA synthesis by in x 28 days Q12 and during therapy.-Obtain
DNA gyrase. inhibiting DNA hypersensitivity, specimens for culture and
Ciprofloxacin gyrase.Therapeutic cross-sensitivity sensitivity before initiating
Therapeutic Effects: Effects:Death of among agents therapy.First dose may be
BRAND Death of susceptible susceptible may occur.Use given before receiving results.
NAME: bacteria. bacteria.Spectrum: cautiously in To prevent development of
Broad activity underlying CNS resistant bacteria,therapy
Fluoroquinolon Spectrum: Broad includes many gram- pathology, renal should only be used to treating
e activity includes many positive pathogens. impairment, infections that are proven or
gram-positive cirrhosis strongly suspected to because
pathogens. by susceptible bacteria.-
Adverse effect: Observe for signs and
CNS: symptoms of anaphylaxis
Seizures,dizzines (rash,pruritus, laryngeal
s,drowsiness,hea edema, wheezing).Discontinue
dache, drug and notify physician
insomnia,acute immediately if these problems
psychoses,agitati occur.
on,
confusion,halluci
nations,increased
intracranial
pressure,tremors.
GI:pseudomemb
ranouscolitis,
abdominalpain,
diarrhea,nausea,
altered tasteGU:
interstitialcystitis
, vaginitisDerm:
rashEndo:hyperg
lycemia,hypogly
caemiaLocal:
phlebitis at
IVsiteMS:
tendinitis,tendon
ruptureMisc:hyp
ersensitivityreact
ions
includinganaphy
laxis,Stevens-
Johnson
 NAME INDICATION ACTION CONTRAINDICA ROUTE AND NURSING
TION/ DOSAGE RESPONSIBILITY
ADVERSE
REACTION
GENERIC Short-term Anti-inflammatory Contraindicated 30mg IV (-)
NAME: managementof pain andanalgesic withsignificant ANST 3 doses Renal impairment,Impaired
(up to 5 days) activity;inhibits renalimpairment, hearing,allergies, hepatic,Skin
Ketorolac prostaglandinsand aspirinallergy, color and lesions,orientation,
Tromethamine leukotriene synthesis recent reflexes,peripheral
GI bleed sensation,clotting times,
BRAND orperforation Use CBC,adventitious soundsBe
NAME: cautiouslywith aware that patientmay be at
impaired hearing; risk for CVevents, GI
Torado allergies; bleeding,renal toxicity,
hepaticconditions monitor accordingly. Keep
emergency equipment readily
Adverse reaction: available at time of initial
dose, in case of severe
CNS:headache,dizzi hypersensitivity
ness,somnolence,ins reaction.Protect drug vials
omnia,fatigue,dizzi from light.Administer every 6
nesstinnitus,ophthal hrs to maintain serum levels
mologic effects and control pain
NAME INDICATION
GENERIC infections caused by sensitive
NAME: staphylococci,streptococci,
pneumococci,
Clindamycin bacteroides,fusibacterium,clo
stridium perfringens, and
other sensitive aerobic and
anaerobic organisms.-
BRAND endocarditis prophylaxis for
NAME: dental procedures in patients
allergic to penicillin-acne
Cleocin, Dalacin vulgaris-bacterial vaginosis-
pneumocystis jiroveci
(carinii) pneumonia-
toxoplasmosis(cerebral or
ocular) immunocompromised
patients
ACTION CONTRAINDIC ROUTE AND NURSING RESPONSIBILITY
ATION/ DOSAGE
ADVERSE
REACTION
Contraindicated in 300mg TIV Q12 assess patients infection before
ANTIBIOTIC; patients and regularly through out
Anti- infectivess hypersensitive to therapy-before giving first dose,
drug or obtain specimen for culture and
lincomycin-use sensitivity test, begin therapy
- inhibits bacterial cautiously in pending results.-monitor renal,
proteinsynthesis patients with renal hepatic,and hematopoetic
by binding to or hepatic disease, functions during prolonged
50Ssubunit of asthma,history of therapy.-be alert for adverse
ribosome.- hinders GI disease, or reactions and drug interactions-if
or killssusceptible significant adverse GI reaction so ccurs,
bacteria allergies monitor patients hydration.-teach
patient how to store oral
CNS: solution.-tell patient to take entire
headacheCV:Thro amount prescribed even after he
mbophlebitisEEN feels better.-warn patient that
T: pharyngitisGI: I.M.injection may be painful-
abdominal instruct patient to report diarrhea
pain,Anorexia, and to avoid self-threatening
bloodyor tarry psudomembranuscolitis-tell
stools,constipation patient receiving drug I.V. to
,diarrhea,dysphagi report discomfort at infusion sit
a,esophagitis,flatul
ence, nausea,
psuedomembranus
colitis, unpleasant
or bitter
taste,vomiting.
NAME INDICATION ACTION CONTRAINDICA ROUTE AND NURSING RESPONSIBILITY
TION/ DOSAGE
ADVERSE
REACTION
GENERIC Indications: Atorvastatin Contraindication: 40g 1 tab OD HS Stress that atorvastatin is an
NAME: Reduction of risk of stroke competitively Hypersensitivity, adjunct to
and heart attack in type 2 inhibits HMG- active liver disease –
Atorvastatin diabetes patients without CoA reductase, the or unexplained not a substitute for low-
evidence of heart disease but enzyme that persistent cholesterol diet
with other CV risk factors, catalyses the elevations of
and revascularization conversion of serum Tell patient to take drug at the
BRAND procedures in patients HMG-CoA to transaminase, same time each day to maintain
NAME: without evidence of coronary mevalonic acid. porphyria, its effects
heart disease (CHD) but with This results in the pregnancy,
Dyslipidaemic multiple risk factors other induction of the lactation Instruct patient to take a missed
than diabetes (eg, smoking, LDL receptors, dose as soon as
HTN, low HDL-C, family leading to lowered possible. If it’s almost time
history of early CHD) LDL-cholesterol for his next dose, he should skip
Patients with CHD, to reduce concentration. the missed dose.
risks of MI, revascularization Absorption:
procedures, hospitalization Rapid from the GI Advise patient to notify
for CHF, and angina tract (oral). prescriber immediately if he
Distribution: develops unexplained muscle
Protein-binding: pain, tenderness, or weakness,
98%. especially if accompanied by
Metabolism: fatigue or fever
Extensively
hepatic; converted
to active inhibitors
of HMG-CoA
reductase.
NAME INDICATION ACTION CONTRAINDICATI ROUTE AND NURSING
ON/ DOSAGE RESPONSIBILITY
ADVERSE
REACTION
GENERIC Carbamazepine Tramadol isused in Tramadol may 50mg TIV Q8 PRN Assess type, location, and
NAME: (Tegretol,Tegretol the management of increasecentral for pain intensity of pain before and
XR ,Equetro,Carbatrol) moderatetomoderately nervous systemand 2-3 hr (peak) after
Tramadol reduces the effect of severe respiratorydepressi administration.
tramadol by increasing pain.Extendedreleaset on whencombined • Assess BP & RR before
BRAND its inactivation in the ablets areused for with and
NAME: body. Quinidine moderate alcohol,anesthetics, periodically
Ultram, Ultram (Quinaglute,Quinidex) tomoderatelyseverech narcotics,tranquiliz duringadministration.
ER reduces the inactivation ronic painin adults ers or Respiratorydepression has
of tramadol ,there by whorequirecontinuous sedativehypnotics. not occurredwith
increasing the treatment for an recommended doses.
concentration of extendedperiod • Assess bowel function
tramadol by50%- routinely. Prevention of
60%.Combining constipation should
tramadol with beinstituted with increased
monoamine oxidase intakeof fluids and bulk
inhibitors (for and withlaxatives to
example,Parnate) minimizeconstipating
effects.
• Assess previous analgesic
history. Tramadol is
notrecommended for
patientsdependent on
opioids or whohave
previously receivedopioids
for more than 1 wk;may
cause opioid
withdrawalsymptoms